Comparison between indacaterol and tiotropium on respiratory function and exercise tolerance in COPD patients

Trial Profile

Comparison between indacaterol and tiotropium on respiratory function and exercise tolerance in COPD patients

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2013 Status changed from recruiting to completed, based on presentation of results.
    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
    • 02 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top